These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31939629)

  • 1. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
    Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
    Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.
    Dong J; Xu M
    Oncol Rep; 2019 Jun; 41(6):3233-3243. PubMed ID: 31002358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a SVM classifier to predict recurrence of ovarian cancer.
    Zhou J; Li L; Wang L; Li X; Xing H; Cheng L
    Mol Med Rep; 2018 Oct; 18(4):3589-3598. PubMed ID: 30106117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A six‑gene support vector machine classifier contributes to the diagnosis of pediatric septic shock.
    Long G; Yang C
    Mol Med Rep; 2020 Mar; 21(3):1561-1571. PubMed ID: 32016447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer.
    Yang J; Bo L; Han T; Ding D; Nie M; Yin K
    Mol Med Rep; 2018 May; 17(5):6345-6356. PubMed ID: 29532879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification.
    Yang L; Sun L; Wang W; Xu H; Li Y; Zhao JY; Liu DZ; Wang F; Zhang LY
    Mol Med Rep; 2018 Feb; 17(2):3005-3013. PubMed ID: 29257283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
    Tuo Y; An N; Zhang M
    Mol Med Rep; 2018 Mar; 17(3):4281-4290. PubMed ID: 29328377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
    Tang Z; Wei G; Zhang L; Xu Z
    Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of recurrent risk-related genes and establishment of support vector machine prediction model for gastric cancer.
    Liu B; Tan J; Wang X; Liu X
    Neoplasma; 2018 Mar; 65(3):360-366. PubMed ID: 29788739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
    Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
    Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 13. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
    Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
    J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit.
    Jiang Y; Xie J; Han Z; Liu W; Xi S; Huang L; Huang W; Lin T; Zhao L; Hu Y; Yu J; Zhang Q; Li T; Cai S; Li G
    Clin Cancer Res; 2018 Nov; 24(22):5574-5584. PubMed ID: 30042208
    [No Abstract]   [Full Text] [Related]  

  • 16. A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
    Liu Y; Zhu D; Xing H; Hou Y; Sun Y
    Oncol Rep; 2019 Mar; 41(3):1521-1530. PubMed ID: 30747226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
    Xu G; Zhang M; Zhu H; Xu J
    Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk gene identification and support vector machine learning to construct an early diagnosis model of myocardial infarction.
    Fang HZ; Hu DL; Li Q; Tu S
    Mol Med Rep; 2020 Sep; 22(3):1775-1782. PubMed ID: 32705275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
    Zhang M; Sun L; Ru Y; Zhang S; Miao J; Guo P; Lv J; Guo F; Liu B
    Int J Mol Med; 2020 Jul; 46(1):252-264. PubMed ID: 32377703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.